Dementia strategy has not cut antipsychotic prescribing in care homes, study findsBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i5182 (Published 23 September 2016) Cite this as: BMJ 2016;354:i5182
- Susan Mayor
A national dementia strategy including recommendations to limit inappropriate use of antipsychotics has not reduced prescribing of these drugs in residential care homes in England, shows a study assessing the policy’s impact.1
The “off label” use of antipsychotics for behavioural and psychological symptoms in dementia has caused concern for some time. The national dementia strategy, launched in the United Kingdom in 2009, recommended that any prescribing of these drugs in people with dementia should …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial